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RESUMEN 
El canal de Ca2+ tipo L cardiaco (Cav 1.2) es factor importante en la repolarización cardiaca y la fuente principal de Ca2+ activador durante 
el acoplamiento excitación-contracción en las células cardiacas. Las fallas en su regulación son causa mayor de arritmias y disfunción 
contráctil. Recientemente demostramos que la proteína del citoesqueletoahnak-1 modula la corriente de Ca2+ a través de los canales Cav 
1.2 (ICaL) al interactuar con la subunidad-β, reguladora, del canal Cav 1.2 y que la variante genética de ahnak-1 I5483T (previamente 
Ile5236Thr), interfiere la estimulación β-adrenérgica de ICaL. 
Estudiar la variante I5483T en cardiomiocitos ventriculares disociados de corazones de rata remodelados después de un infarto (PMI).. 
Se utilizó la técnica de “patch-clamp” para registrar ICaL en miocitos ventriculares, disociados enzimáticamente, de ratas jóvenes (2 meses) 
y de ratas “sham” y PMI de seis meses. 
La ICaL basal se incrementó de 11±0,5 A/F en cardiomiocitos jóvenes a 14,6±1,1 A/F y 15,7±1 A/F en cardiomiocitos “sham” y PMI, res-
pectivamente, mientras que el isoproterenol (ISO, 1 μmol/L)  incrementó ICaL en 101±6%, 109±10% y 104±12%, respectivamente, por en-
cima de los valores basales. Cuando las células se perfundieron intracelularmente con un péptido de ahnak-1 que contenía la secuencia 
mutada (10 μmol/L) la ICaL basal se incrementó a 20±1 A/F, 22±2 A/F y 21±2 A/F en cardiomiocitos jóvenes, “sham” y PMI, respectiva-
mente. En esas células el ISO aumentó ICaL en 11±4%, 33±6% y 79±12% respectivamente. 
La modulación de ICaL por la ahnak-1 está afectada por la isquemia miocárdica y la remodelación. Como la ahnak-1 y los canales Cav 1.2 
están co-localizados en el sistema T-tubular transverso, la remodelación pudiera afectar la interacción de la ahnak-1 con la subunidad re-
guladora β de esos canales. 
 Palabras Clave: ahnak-1, canales de calcio, patch-clamp, corazón, cardiomiocitos, infarto del miocardio. 
 
 
ABSTRACT 
 
The L-type cardiac Ca2+ channel (Cav 1.2) is an important determinant of cardiac repolarization and the main source of activator Ca2+ dur-
ing excitation-contraction coupling in cardiac cells. Its defective regulation is a major cause of arrhythmias and contractile dysfunction. We 
have recently shown that the cytoskeletal protein ahnak-1 modulates Ca2+ current through Cav 1.2 channels (ICaL) by interacting with the 
regulatory β-subunit of the Cav 1.2 channel and that the genetic variant of ahnak-1 I5483T (previously Ile5236Thr), interferes with the β-
adrenergic stimulation of ICaL. 
To extend our study of the I5483T variant to ventricular cardiomyocytes dissociated from remodelled infarcted rat hearts (PMI). 
The patch-clamp technique was used to record ICaL from enzymatically dissociated ventricular cardiomyocytes from young (2-month-old) 
and six-month-old sham-operated and PMI rats. 
Basal ICaL was increased from 11±0,5 A/F in young cardiomyocytes to 14.6±1.1 A/F and 15.7 ± 1 A/F in sham and PMI cardiomyocytes 
respectively, while isoprenaline (ISO, 1 μmol/L) further increased ICaL by 101±6%, 109±10% and 104±12% respectively. When cells were 
intracellularly perfused with a peptide containing the mutated ahnak-1 sequence (10 μmol/L) basal ICaL was increased to 20±1 A/F, 22±2 
A/F and 21±2 A/F in young, sham and PMI cardiomyocytes respectively. In these cells ISO increased ICaL by 11±4%, 33±6% and 79±12% 
respectively. 
Modulation of ICaL by ahnak-1 is impaired by myocardial ischemia and remodelling. Since ahnak-1 and Cav 1.2 channels co-localize in the 
transverse T-tubule system, remodelling of T-tubules could affect the interaction of ahnak-1 with the regulatory β-subunit of these channels. 
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INTRODUCTION 
 
The Cav1.2 L-type Ca
2+ channel (LTCC) of car-
diomyocytes is a complex multimeric molecular 
sarcolemmal ensemble1 and is mostly localized in 
the transverse tubular system of cardiomyo-
cytes.2,3 Activation of LTCC generates a Ca2+ cur-
rent (ICaL) through the sarcolemma large enough to 
be involved in the control of action potential dura-
tion4 and serves as a trigger for Ca2+ release from 
the sarcoplasmic reticulum during the excitation-
contraction coupling (the “calcium-induced cal-
cium release”).1,4-6 
The typical structure of LTCC in ventricular car-
diomyocytes is a macromolecular multimeric 
complex consisting of a pore-forming unit α1C, an 
intracellular β (mostly β2) subunit and the dimer 
α2δ (α2δ-1) subunit in a 1:1:1 ratio1,7. The α1C sub-
unit contains all the necessary structures to allow 
the channel to gate and confers the Ca2+ selecti-
vity as well as the electrophysiological and phar-
macological properties of the LTCC.7-10 The β and 
α2δ subunits seem to be involved in membrane 
targeting of α1C and influence LTCC inactivation.9-
12 
It has been consistently reported that L-type 
Ca2+ channel activity can be modulated by the 
cytoskeleton.13 Recently, the giant cytoskeletal 
protein ahnak-1 (5890 amino acids) has emerged 
as an important modulator of β-adrenergic regula-
tion of the cardiac L-type Ca2+ channel (for a re-
cent review see 14). Haase et al.,15 and Hohaus et 
al.,16 provided evidence that ahnak-1 could have a 
physiological role in cardiac β-adrenergic signal-
ling via its interaction with the regulatory β-subunit 
of the L-type Ca2+ channel. Later on, we showed 
that intracellular perfusion of rat ventricular car-
diomyocytes with small ahnak-1 fragments in-
volved in high affinity (KD~50 nM) interaction of the 
ahnak-1 distal C-terminus (C2) with the β2-subunit 
induced an increase in ICaL density and slowed 
down its inactivation.17 That ahnak-1 C1 terminus-
derived fragments also modulate ICaL was further 
confirmed by Haase et al.,18 who demonstrated 
that the ahnak-1 polymorphism, I5483T (previously 
Ile5236Thr) interferes with β-adrenergic stimulation 
of ICaL. The proximal ahnak-1 C terminus (C1) con-
tains multiple interaction sites with the β-subunit. 
Intracellular application of this mutated peptide to 
rat ventricular cardiomyocytes increased ICaL by 
~60% and slowed down its fast inactivation time 
constant together with a leftward shift of its avai-
lability curve. These effects were similar to those 
observed after β-adrenergic stimulation in control 
cardiomyocytes. The response of ICaL of rat ven-
tricular cardiomyocytes intracellularly perfused 
with the I5483T-ahnak-1 fragment to β-adrenergic 
stimulation was greatly diminished. Interpretation 
of these data was that in rat ventricular cardiomyo-
cytesahnak-1 could serve as a “physiological 
brake” on ICaL when normally attached to the β-
subunit. Relief of this inhibition during β-adrenergic 
stimulation or when ahnak-1-derived peptides are 
intracellularly applied increases ICaL and changes 
its inactivation time course.18 This interpretation 
has been recently challenged by our results with 
cardiomyocytes dissociated from mice that do not 
express ahnak-1(KO) in which ICaL density was not 
increased as expected for an autoinhibitor.19,20 
However, the lack of increase in ICaL density in KO 
cardio-myocytes could be also related to a disrup-
tion of the cytoskeleton integrity13 and/or to a de-
crease in plasma membrane expression of L-type 
Ca2+ channels.21 The role of ahnak-1 as a modula-
tor of ICaL is reinforced by experiments demonstrat-
ing that perfusion of KO ventricular cardiomyo-
cytes with small fragments encompassing the 
amino acids of ahnak-1 C terminus involved in ICaL 
regulation had no effect on this ionic current.19,20 
However, it is not known whether the ahnak-1 
modulator role is altered or not in pathological 
states. It has been reported that in remodelled 
post myocardial infarcted (PMI) hearts, ICaL density 
is decreased or not affected.7 More consistently its 
inactivation time course is reported to be slower in 
PMI cardiomyocytes.7,22 It has been also reported 
that the transverse tubular system (T-system) is 
remodelled in failing hearts23-25 a fact that could 
partially account for the observed changes in ICaL 
because most of the Cav 1.2 channels are ex-
pressed in the T-system. Because ahnak-1 and the 
Cav 1.2 channels co-localize in the T-system,
15-16 
the modulator activity of ahnak-1 on Cav 1.2 chan-
nels could be altered in remodelled PMI cardio-
myocytes. It was thus the aim of the present inves-
tigation, to characterize the well-documented 
modulator activity of the I5483T polymorphism18 
on Cav 1.2 channels of cardiomyocytes isolated 
from PMI rat ventricles.22 Since the genetic variant 
I5483T of ahnak-1 is functional and may cause 
individual differences in ICaL response upon phy-
siological challenges or therapeutic interventions, 
it is important to address the issue whether the 
interaction of ahnak-1 with the cardiac Ca2+ chan-
nel could be altered in pathological states. 
 
METHOD 
 
I5483T polymorphism 
The synthetic ahnak-1 peptides, either wild-type 
(GGLPGIGVQGLE; from here on GIG) or mutated 
(GGLPGTGVQGLE, fromhere on GTG), corre-
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sponding   to   amino   acid   positions  5478-5489 
of ahnak-1 were purchased from Biosyntan GmbH 
(Berlin-Buch, Germany; see 18 for details). 
Myocardial infarction model in rats 
 
Male Wistar rats weighing 180-230g were sub-
mitted to left anterior coronary ligation according 
to Aimondet al.22 In brief, rats were anaesthetized 
with an intraperitoneal mixture of ketamine (150 
mg/kg) and chlorpromazine (15 mg/kg) before 
being intubated and ventilated. After median-left 
thoracotomy and opening of the pericardium, the 
left coronary artery was occluded with a 7-0 silk 
suture at the apex. Successful occlusion was re-
cognized by pallor of anterior left ventricular free 
wall and by the occurrence of immediate regional 
dyskinesia. Sham-operated rats were submitted to 
the same treatment except the coronary artery 
ligation. Data concerning heart and haemody-
namic status of sham-operated and PMI Wistar 
rats used in this study have been previously pub-
lished.22,26 Typically in PMI rats, left ventricles were 
markedly dilated under M-mode echocardiography 
and heart weight/body weight was increased by ~ 
40% despite large infarcted area while end-
diastolic pressure demonstrated a significant in-
crease. 
 
Isolation of adult ventricular cardiomyocytes 
 
Single ventricular cells from young (2-month-
old), sham-operated and PMI rat hearts (4 months 
after surgery, 6-month-old) were dispersed by an 
enzymatic method similar to that previously de-
scribed.17 Isolated myocytes were kept in this 
physiological solution (Ca2+=1 mmol/l) at room 
temperature (21°C-23°C) and used within 6-8 
hours. 
 
Patch-clamp recordings 
 
For recording the L-type Ca-current (ICaL), the 
whole cell variant of the patch-clamp method was 
used. K+-currents were blocked by Cs (intracellu-
lar and extracellular; see below), respectively. The 
fast inward Na+ current was blocked with tetro-
dotoxin (TTX) at a concentration of 50 μmol/L. The 
composition of the standard extracellular solution 
was (mmol/L): NaCl, 117; CsCl, 20; CaCl2, 2; 
MgCl2,1.8; glucose, 10; HEPES, 10; pH was ad-
justed to 7.4 at 21EC. The pipette ("intracellular") 
solution contained (mmol/L): CsCl, 130; Na2-GTP, 
0.4; Na2-ATP, 5; Na2-creatinphosphate, 
5;ethyleneglycol-bis-(β-aminoethylether)N,N,N',N'-
tetraacetic acid (EGTA), 11; CaCl2 4.7 (free 
Ca2+~120 nmol/l); HEPES, 10; pH was adjusted to 
7.2 with CsOH. 
For routine monitoring of currents, cells 
wereclamped by 300-ms voltage-clamp pulses to 0 
mV from a holding potential of -80 mV at a fre-
quency of 0.25 Hz. Current amplitude was esti-
mated as the difference between peak inward cur-
rent and the current level at the end of the 200-ms 
pulse. Cells intracellularly perfused with GIG or 
GTG (10 μmol/L) were let to stabilize for at least 5 
minutes after patch rupture before beginning the 
experiment. Current-to-voltage relationships (I/V) 
and availability curves (f4vsVm) were determined by 
standard double-pulse protocols.17 Availability 
curves of ICaL were fitted from -80 to 0 mV by a 
Bolztmann distribution of the type: f4 = 1/1 + exp 
[(Vm-Vf)/s], where Vf is the potential for half inacti-
vation and s the slope factor. Pulse generation, 
data acquisition and on-line analysis were done, 
using computer facilities and ACQUIS1 software 
(version 2.0, CNRS License, France). 
 
Statistical evaluation 
 
Results were analysed by the Students' “t”-test 
and are expressed as means and standard errors 
of means. The criterion for significance was 
p<0.05. 
 
RESULTS 
 
Characteristics of L-type Ca2+ currents from 
control young, sham and PMI cardiomyocytes are 
shown in Table 1. As can be seen ICaL density was 
significantly (p<0.05) increased in sham and PMI 
cardiomyocytes. Inactivation time course of ICaL 
was barely affected except for the slow inactivation 
time constant of ICaL in PMI cardiomyocytes in 
which it was significantly greater. Potentials for half 
inactivation (V0.5) and slope factors of availability 
curves were not significantly different. Under con-
trol condition, isoproterenol (ISO, 1 μmol/L) in-
creased ICaL by about 100% in the three popula-
tions of cardiomyocytes together with a 5 mV left-
ward shift of V0.5 (Table 1). In each case, a small 
but significant increase in the fast inactivation time 
constant of ICaL was observed. 
Intracellular perfusion of cardiomyocytes from  
young (N=8), sham (N=7) and PMI (N=9) hearts 
with 10 μmol/L GIG (the wild-type peptide) had no 
effect on basal ICaL nor on its response to 1 μmol/L 
isoproterenol (data not shown). However, when 
cardiomyocytes were intracellularly perfused with 
10 μmol/L GTG, basal ICaL was significantly in-
creased in the three cell populations (Table 1).  
Nevertheless, it is to note that while in young 
cardiomyocytes basal ICaL was increased by ~81%   
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Tabla1. ICaL characteristics of cardiomyocytes dissociated from young, sham and PMI hearts. Control refers to the values obtained with standard extracellular solution.  
GTG refers to cardiomyocytes intracellularly perfused with the ahnak1 peptide GGLPGTGVQGLE(10 μmol/L). ISO: isoproterenol 1 μmol/L 
 
 
*: p<0.05 with respect to the previous control condition. **: p<0.05 with respect to cardiomyoctesintracellulary perfused with control solution. ***: p<0.05 with 
respect to young cardiomyocytes. dICaL: L-type Ca
2+ current density. ϑfast : Fast inactivation time constant. ϑslow : Slow inactivation time constant. V0.5 : Potential for half 
availability. s: slope factor. 
 
 
 
 
Figure 1.Effects of intracellular perfusion with GTG on basal ICaL and on its 
response to β-adrenergic stimulation. The graph summarizes the main 
finding from Table 1 and represents the percent increase of ICaL (mean ± 
SEM) by ISO (1 μmol/L) as a function of GTG (10 μmol/L) effect on basal ICaL 
(percent increase of basal ICaL expressed as mean ± SEM) in Young, Sham 
and PMI cardiomyocytes. As can be seen, the lower the effect of GTG 
perfusion on basal ICaL (PMI cardiomyocytes), the higher the increase in ICaL 
by ISO. 
 
Figure 2.Effect of intracellular perfusion with GTG on the washout of ISO 
effect on ICaL  in PMI cardiomyocytes. ICaL was recorded from two different 
PMI cardiomyocytes, one perfused with control intracellular solution (, 
Control) and the other with an intracellular solution containing GTG (10 
μmol/L; Ο, GTG). The horizontal line indicates extracellular perfusion with 
ISO (1 μmol/L; ~ 2 min). Currents were normalized to the maximal ISO effect 
and are expressed in arbitrary units (au). The speed of washout of ISO effect 
in each PMI cardiomyocyte is presented as the slope of the decay of ICaL in 
au / min. As can be seen, washout of ISO effect is much slower in the cardio-
myocyte intracellularly perfused with GTG. 
   
 dICaL (A/F) ϑfast (ms) ϑslow (ms) V0.5 (mV) s (mV) 
YOUNG (N = 8)      
Control 11.1 ± 0.5 5.1 ± 0.3 51.0 ± 2.8 -32.5 ± 1.4 5.1 ± 0.5 
+ ISO 22.4 ± 1.3* 6.7 ± 0.2* 50.2 ± 1.9 -37.6 ± 1.5* 5.2 ± 0.4 
% increase by ISO 101 ± 6     
GTG - YOUNG (N = 8)      
Control 20.1 ± 0.8** 6.6 ± 0.3** 52.8 ± 2.3 -36.7 ± 2.0** 5.3 ± 0.5 
ISO 22.3 ± 1.2 6.9 ± 0.4 49.7 ± 1.8 -37.1 ± 2.1 5.2 ± 0.5 
% increase by ISO 11 ± 4**     
SHAMS  (N = 9)      
Control 14.6 ± 1.1*** 5.4 ± 0.6 54.2 ± 2.6 -32.3 ± 1.4 5.2 ± 0.7 
+ ISO 29.7 ± 1.6* 6.7 ± 0.6* 50.1 ± 3.2 -37.6 ± 2.0* 5.1 ± 0.6 
% increase by ISO 109.0 ± 10.4     
GTG - SHAMS  (N = 9)      
Control 22.1 ± 2.1** 5.3 ± 0.3 57.1 ± 4.7 -37.1 ± 1.9** 5.3 ± 0.5 
+ ISO 29.3 ± 3.0* 7.1 ± 1.0* 53.3 ± 2.6 -38.0 ± 2.0 5.2 ± 0.5 
% increase by ISO 33.3 ± 5.5***     
PMI  (N = 15)      
Control 15.7 ± 0.9*** 5.1 ± 0.4 74.4 ± 7.8** -33.2 ± 2.2 5.4 ± 0.4 
+ ISO 32.1 ± 2.6* 6.9 ± 0.3* 58.7 ± 4.2 -37.8 ± 2.1* 5.3 ± 0.5 
% increase by ISO 104.0 ± 11.7     
GTG - PMI  (N = 18)      
Control 20.7 ± 1.5** 5.3 ± 0.4 69.3 ± 6.5** -36.4 ± 2.3** 5.3 ± 0.4 
+ ISO 36.1 ± 3.0* 6.4 ± 0.4* 61.8 ± 4.2** -37.8 ± 2.2 5.4 ± 0.6 
% increase by ISO 78.7 ± 12.3***     
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(compare with 18), in sham and PMI cardiomyo-
cytes ICaL was increased by 52% and 32% respec-
tively (Table 1). As previously reported18 the fast 
inactivation time constant of ICaL in young cardio-
myocytes was slightly increased; however, there 
were no significant effects of GTG on the inactiva-
tion time course of ICaLof sham and PMI cardio-
myocytes. In agreement with our previous re-
sults18, ISO (1 μmol/L) barely (~11%) increased 
ICaL in cardiomyocytes from young hearts (Table 
1). 
However, in sham and PMI cardiomyocytes 
ISO was able to increase ICaL by ~33% and 78% 
respectively (Table 1). Figure 1 summarizes these 
results. In these cells, the behaviour of ICaL inacti-
vation time course under β-adrenergic stimulation 
was not different from control cells. 
Full washout of ISO effects on ICaL usually re-
quired 4 to 5 min regardless of cardiomyocytes 
condition, i.e. whether they come from young, 
sham or PMI hearts. The same was true for GTG 
(intracellularly) -perfused cardiomyocytes from 
young and sham hearts. However, in PMI cardio-
myocytes intracellularly perfused with GTG, more 
than 10 min were needed for a full washout of ISO 
effects on ICaL. Figure 2 illustrates an example 
ofISO effects and recovery in two PMI cardiomyo-
cytes, one in control condition and the other in-
tracellularly perfused with GTG. 
 
DISCUSSION 
 
The present study confirms and extends our 
previous results,18 on the role of ahnak-1 C1-
terminus in β-adrenergic regulation of cardiac L-
type Ca2+ channels and suggest that cardiac 
remodelling after infarction could modify this 
modulator role of ahnak-1 on the Cav 1.2 channel. 
Ahnak-1 C-terminus interacts with the β2-
subunit of the cardiac Cav 1.2 Ca
2+ channel via 
multipoint attachment sites.16 The roles of some of 
these sites in the modulation of Cav 1.2 Ca
2+ 
channel have been demonstrated. We have 
shown that targeting the high affinity interaction 
sites located in the ahnak-1 C2-terminus (aa 5535-
5890) increased ICaL amplitude and slowed down 
its inactivation time course.17,19 Our group also 
demonstrated that the ahnak-1 C1-terminus (aa 
4889-5535) contains several amino acid se-
quences able to modulate ICaL inactivation.
20 In-
terestingly, the genetic variant of a short amino 
acid sequence in the C1-terminus (I5483T) is able 
to mimic the β-adrenergic response of ICaL. Car-
diomyocytes from young rat hearts intracellularly 
perfused with the peptide fragment correspond-
ing to this polymorphism (GTG) show an in-
creased ICaL density that was barely further in-
creased by the well-known β-adrenergic agonist 
isoproterenol.18 The increase in ICaL by the intra-
cellular GTG fragment was not affected by acetyl-
choline clearly indicating that it had no action on 
the β-adrenergic intracellular signalling cascade. 
The present results confirm these previous find-
ings of the GTG action in cardiomyocytes from 
young rat hearts: in GTG-perfused cardiomyo-
cytes basal ICaL density was increased by ~81% 
with respect to control cells and ISO was hardly 
effective (~11%) in increasing further ICaL.  
A different picture emerged in the experiments 
using cardiomyocytes from sham and PMI rat 
hearts. Both sham and PMI cardiomyocytes 
showed, under control conditions, ICaL densities 
that were significantly greater than ICaL from 
young cardiomyocytes a fact that is indicative of 
the myocardial remodelling that occurs with age 
and especially after ischemia.7,22 Interestingly, the 
response of ICaL to β-adrenergic stimulation of 
these cardiomyocytes was not changed. How-
ever, the response of ICaL to intracellular GTG in 
sham and PMI cardiomyocytes was different from 
young cardiomyocytes. In sham and PMI cardio-
myocytes basal ICaL was increased by intracellular 
GTG by 51% and 32%, respectively. More “strik-
ingly”, ISO was able to further increase ICaL by 
33% and 78% in sham and PMI cardiomyocytes, 
respectively in clear contrast to the almost lack of 
effect of β-adrenergic stimulation in young car-
diomyocytes in the presence of GTG. One possi-
ble explanation for this finding is that remodelling 
affects the interaction between ahnak-1 and the 
β2-subunit of the Cav 1.2 Ca2+ channel. It has 
been shown that ahnak-1 is mainly expressed in 
the sarcolemma including the transverse tubular 
system.15,16 The Cav 1.2 Ca
2+ channel complex is 
mainly localized in the T-system.3 Partial loss of 
the T-system, T-tubule disorganization and altera-
tions in the crosstalk between Cav 1.2 Ca
2+ chan-
nels and ryanodine receptors of the sarcoplasmic 
reticulum due to T-tubule remodelling have been 
reported in failing hearts.23-25,27,28 It is then con-
ceivable that in failing hearts (such as PMI hearts) 
interaction of ahnak-1 with the β subunit of the Cav 
1.2 channel is modified thus accounting for the 
differential results we found in young, sham and 
PMI cardiomyocytes in which a lower effect of 
GTG on basal ICaL (PMI cardiomyocytes) corres-
ponds to a higher response of ICaL to β-adrenergic 
stimulation (see Figure 1). It is to note here that 
GTG-perfused PMI cardiomyocytes also showed 
longer washout times of ISO effect. However, at 
this moment, the precise mechanism of how T-
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tubule remodelling could affect ahnak-1 interac-
tion with the β subunit  of  the Cav 1.2 Ca2+ chan-
nel remains to be  elucidated. This  proposal does 
not exclude other speculative explanations such 
as “internalization” of ahnak-1 during ischemia 
(Morano et al., unpublished results) and/or re-
expression of species-specific isoforms of β sub-
units (and/or α1C subunit) that could occur upon 
myocardial remodelling thus modifying the inter-
actions with ahnak-1. 
Taken together, our data highlight the impor-
tance of ahnak-1 for cardiac Ca2+ channel func-
tion. Although it is still difficult to extrapolate the 
present findings to the clinical setting, we should 
emphasize two important things demonstrated by 
our results. First, disruption of ahnak-1 - Ca2+ 
channel interaction (by the intracellularly-perfused 
ahnak-1 fragments) results in an increase in Ca2+ 
current and a slowing down of its inactivation, i.e. 
a “gain of function”. Second, the action of these 
peptides mimics the situation in remodelled 
hearts in which the interaction between the two 
molecular partners (ahnak-1 and  Ca2+ channels) 
is disrupted due to remodelling of the T-tubular 
system.23-25 The resulting “gain of function” 
causes a delayed cardiomyocyte repolarization 
(long QT) and, more important, intracellular Ca2+ 
overload, two factors that increase the risk of ar-
rhythmias. That lethal arrhythmias could occur by 
a slower Ca2+ channel inactivation has recently 
been shown for Timothy’s syndrome29. Besides 
contributing to a better understanding of the ex-
tremely complex process of ventricular remodel-
ling after ischemia (an important clinical condi-
tion), our study identifies new players (and poten-
tial new therapeutic targets) contributing to the 
ultimate cause of ventricular remodelling, the 
intracellular Ca2+ overload. 
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